• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管内皮生长因子治疗糖尿病黄斑水肿研究中光学相干断层扫描特征的预测价值。

PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY.

机构信息

Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Research Institute GUIDE, University of Groningen, Groningen, the Netherlands.

出版信息

Retina. 2018 Apr;38(4):812-819. doi: 10.1097/IAE.0000000000001626.

DOI:10.1097/IAE.0000000000001626
PMID:28406860
Abstract

PURPOSE

To establish the predictive value of specific optical coherence tomography retinal features on visual outcomes and retinal thickness during anti-vascular endothelial growth factor treatment in patients with diabetic macular edema.

METHODS

Post hoc analysis of compound data of a prospective, 6-month, multicenter, randomized controlled trial of 119 patients with diabetic macular edema receiving either intravitreal bevacizumab or ranibizumab were analyzed to assess the associations between baseline retinal morphologic parameters and change in best-corrected visual acuity and central subfield thickness. Based on the study protocol of the core study, best-corrected visual acuity and central subfield thickness were obtained before each mandatory monthly injection during 6 months.

RESULTS

The presence of serous retinal detachment at baseline was associated with significant improvement in best-corrected visual acuity letter score at Month 3 and Month 6 (P < 0.001 and P = 0.01, respectively). In addition, the presence of disorganization of retinal inner layers was associated with lower best-corrected visual acuity letter score at Month 3 and Month 6 (P < 0.05 and P = 0.01, respectively).

CONCLUSION

This study found that serous retinal detachment and disorganization of retinal inner layers were associated with different treatment responses to anti-vascular endothelial growth factor therapy in patients with diabetic macular edema.

摘要

目的

确定特定的光学相干断层扫描视网膜特征在糖尿病性黄斑水肿患者接受抗血管内皮生长因子治疗期间对视力结果和视网膜厚度的预测价值。

方法

对一项前瞻性、6 个月、多中心、随机对照试验的复合数据进行了事后分析,该试验共纳入 119 例糖尿病性黄斑水肿患者,分别接受玻璃体内贝伐单抗或雷珠单抗治疗,以评估基线视网膜形态参数与最佳矫正视力和中心凹下视网膜厚度变化之间的关系。根据核心研究的研究方案,在 6 个月期间每次强制性每月注射前均获得最佳矫正视力和中心凹下视网膜厚度。

结果

基线时存在浆液性视网膜脱离与第 3 个月和第 6 个月最佳矫正视力字母评分的显著改善相关(P < 0.001 和 P = 0.01)。此外,视网膜内层紊乱与第 3 个月和第 6 个月的最佳矫正视力字母评分较低相关(P < 0.05 和 P = 0.01)。

结论

本研究发现,浆液性视网膜脱离和视网膜内层紊乱与糖尿病性黄斑水肿患者接受抗血管内皮生长因子治疗的不同治疗反应相关。

相似文献

1
PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY.抗血管内皮生长因子治疗糖尿病黄斑水肿研究中光学相干断层扫描特征的预测价值。
Retina. 2018 Apr;38(4):812-819. doi: 10.1097/IAE.0000000000001626.
2
CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.不同模式糖尿病黄斑水肿中光学相干断层扫描高反射灶与视力预后的相关性
Retina. 2016 Sep;36(9):1630-9. doi: 10.1097/IAE.0000000000000995.
3
Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.玻璃体内注射雷珠单抗治疗伴有浆液性视网膜脱离的糖尿病性黄斑水肿的疗效
Korean J Ophthalmol. 2018 Aug;32(4):296-302. doi: 10.3341/kjo.2017.0117.
4
OPTICAL COHERENCE TOMOGRAPHY BASELINE PREDICTORS FOR INITIAL BEST-CORRECTED VISUAL ACUITY RESPONSE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN EYES WITH DIABETIC MACULAR EDEMA: The CHARTRES Study.光学相干断层扫描基线预测因子与糖尿病性黄斑水肿眼玻璃体内抗血管内皮生长因子治疗的初始最佳矫正视力反应:CHARTRES 研究。
Retina. 2018 Jun;38(6):1110-1119. doi: 10.1097/IAE.0000000000001687.
5
RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better.糖尿病性黄斑水肿治疗期间视网膜各层对雷珠单抗的反应:并非越薄越好。
Retina. 2016 Jul;36(7):1314-23. doi: 10.1097/IAE.0000000000000923.
6
HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA.抗血管内皮生长因子治疗累及黄斑中心的糖尿病性黄斑水肿后的高反射性视网膜斑点与视觉功能
Retina. 2016 Jul;36(7):1298-308. doi: 10.1097/IAE.0000000000000912.
7
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗持续性弥漫性糖尿病性黄斑水肿。
Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.
8
A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.一项玻璃体内注射贝伐单抗与雷珠单抗治疗糖尿病黄斑水肿的前瞻性随机试验。
Am J Ophthalmol. 2013 Sep;156(3):502-510.e2. doi: 10.1016/j.ajo.2013.04.026. Epub 2013 Jun 21.
9
Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema.玻璃体腔内雷珠单抗对糖尿病黄斑水肿患者视网膜内硬性渗出的影响。
Am J Ophthalmol. 2020 Mar;211:183-190. doi: 10.1016/j.ajo.2019.11.014. Epub 2019 Nov 20.
10
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.一种用于比较疗效的交叉设计:贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿的36周随机试验。
Ophthalmology. 2016 Apr;123(4):841-9. doi: 10.1016/j.ophtha.2015.11.021. Epub 2016 Feb 10.

引用本文的文献

1
Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study).现实世界中糖尿病性黄斑水肿患者的抗VEGF治疗转换:雷珠单抗与阿柏西普用于贝伐单抗治疗无反应的糖尿病性黄斑水肿患者(SWIRL研究)
BMJ Open Ophthalmol. 2025 Aug 1;10(1):e002178. doi: 10.1136/bmjophth-2025-002178.
2
Characterization of the Disorganization of the Inner Retinal Layers in Diabetics Using Increased Axial Resolution Optical Coherence Tomography.利用提高轴向分辨率的光学相干断层扫描技术对糖尿病患者视网膜内层结构紊乱的特征分析
Transl Vis Sci Technol. 2025 Jan 2;14(1):12. doi: 10.1167/tvst.14.1.12.
3
Ultrastructural imaging biomarkers in diabetic macular edema: A major review.
糖尿病性黄斑水肿中的超微结构成像生物标志物:一项主要综述。
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S7-S23. doi: 10.4103/IJO.IJO_878_24. Epub 2024 Dec 24.
4
A deep learning approach to hard exudates detection and disorganization of retinal inner layers identification on OCT images.基于深度学习的 OCT 图像硬性渗出物检测及视网膜内层紊乱识别方法。
Sci Rep. 2024 Jul 19;14(1):16652. doi: 10.1038/s41598-024-63844-9.
5
A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment.一项用于及时评估抗 VEGF 眼内注射治疗抵抗的糖尿病黄斑水肿的真实世界研究。
Front Endocrinol (Lausanne). 2023 May 17;14:1108097. doi: 10.3389/fendo.2023.1108097. eCollection 2023.
6
Prevalence and clinical implications of subretinal fluid in retinal diseases: a real-world cohort study.视网膜疾病中视网膜下液的患病率及其临床意义:一项真实世界的队列研究。
BMJ Open Ophthalmol. 2023 Feb;8(1). doi: 10.1136/bmjophth-2022-001214.
7
Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice.临床实践中玻璃体内注射抗血管内皮生长因子治疗糖尿病性黄斑水肿的治疗结果预测因素
Int J Retina Vitreous. 2023 Apr 4;9(1):23. doi: 10.1186/s40942-023-00453-0.
8
The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.玻璃体内皮质类固醇在 DME 治疗中的作用:预测性 OCT 生物标志物。
Int J Mol Sci. 2022 Jul 8;23(14):7585. doi: 10.3390/ijms23147585.
9
Optical coherence tomography patterns of diabetic macular edema and treatment response to bevacizumab: a short-term study.糖尿病性黄斑水肿的光学相干断层扫描模式及对贝伐单抗的治疗反应:一项短期研究。
Ther Adv Ophthalmol. 2022 Mar 31;14:25158414221074519. doi: 10.1177/25158414221074519. eCollection 2022 Jan-Dec.
10
Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema.光学相干断层扫描血管造影生物标志物可预测糖尿病性黄斑水肿患者对贝伐单抗的解剖学反应。
Diabetes Metab Syndr Obes. 2022 Feb 9;15:395-405. doi: 10.2147/DMSO.S351618. eCollection 2022.